Drug Manufacturer to Pay $ 225 Million to End Opioid Investigations



[ad_1]

reInsys Therapeutics Inc., a rug manufacturer, has agreed to pay $ 225 million to stop federal investigations into allegations that it used illegal marketing tactics to promote a powerful opioid analgesic.

Federal prosecutors allege that the company used bribes and veiled bribes to sell a fentanyl spray called Susbys for cancer patients suffering from acute pain.

The company agreed to pay a $ 2 million criminal fine and confiscate $ 28 million. In addition, Insys has agreed to pay $ 195 million to settle civil allegations, according to the Associated Press.

US lawyer Andrew Lelling said the company has benefited for years while contributing to the opioid epidemic in the United States, which has claimed the lives of hundreds of thousands of people.

"For years, Insys has been engaging in illegal and prolonged behavior that prioritized its benefits over the health of the thousands of patients who depended on it," said Lelling.

Insys executives, including 76-year-old founder John Kapoor, were convicted of racketeering charges last month. The Boston trial revealed tactics used to persuade physicians to prescribe medications, including providing presenters with fees for events presented as educational workshops for physicians.

Other tactics included convincing former strippers to give their doctors dance tricks and produce a rap video featuring higher doses of drugs.

The charges against Kapoor and others are punishable by up to 20 years. The executives denied any wrongdoing.

[ad_2]

Source link